NASDAQ:AMIX - Nasdaq - US05330T2050 - Common Stock - Currency: USD
2.965
+0.03 (+1.19%)
The current stock price of AMIX is 2.965 USD. In the past month the price decreased by -0.84%. In the past year, price decreased by -96.65%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
SYK | STRYKER CORP | 31.4 | 145.92B | ||
MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
DXCM | DEXCOM INC | 53.81 | 34.68B | ||
RMD | RESMED INC | 26.21 | 34.03B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Autonomix Medical Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in The Woodlands, Texas and currently employs 5 full-time employees. The company went IPO on 2024-01-29. Autonomix Medical, Inc. is a medical device company, which is focused on advancing technologies to treat diseases involving the peripheral nervous system. Its technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate peripheral neural signals with up to 1,000 times sensitivity. The company is developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. The company is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation, and chronic pain management across a disease spectrum. Its Autonomix catheter is equipped with a microchip that converts analog signals from the body to a digital signal that can be sent directly to a computer screen.
AUTONOMIX MEDICAL INC
21 Waterway Ave, Suite 300
The Woodlands TEXAS US
Employees: 7
Company Website: https://autonomix.com/
Phone: 18322777816
The current stock price of AMIX is 2.965 USD. The price increased by 1.19% in the last trading session.
The exchange symbol of AUTONOMIX MEDICAL INC is AMIX and it is listed on the Nasdaq exchange.
AMIX stock is listed on the Nasdaq exchange.
7 analysts have analysed AMIX and the average price target is 28.56 USD. This implies a price increase of 863.24% is expected in the next year compared to the current price of 2.965. Check the AUTONOMIX MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
AUTONOMIX MEDICAL INC (AMIX) has a market capitalization of 5.25M USD. This makes AMIX a Nano Cap stock.
AUTONOMIX MEDICAL INC (AMIX) currently has 7 employees.
AUTONOMIX MEDICAL INC (AMIX) has a support level at 2.64 and a resistance level at 2.98. Check the full technical report for a detailed analysis of AMIX support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AMIX does not pay a dividend.
AUTONOMIX MEDICAL INC (AMIX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-14.01).
The outstanding short interest for AUTONOMIX MEDICAL INC (AMIX) is 11% of its float. Check the ownership tab for more information on the AMIX short interest.
ChartMill assigns a fundamental rating of 1 / 10 to AMIX. The financial health of AMIX is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months AMIX reported a non-GAAP Earnings per Share(EPS) of -14.01. The EPS decreased by -18089.44% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -261.16% | ||
ROE | -463.24% | ||
Debt/Equity | 0.36 |
ChartMill assigns a Buy % Consensus number of 86% to AMIX. The Buy consensus is the average rating of analysts ratings from 7 analysts.